Kåre is heading EMA/EU related activities within pharmacovigilance at the Danish Medicines Agency and has since 2015 been focusing on safety surveillance. He has a broad background following 15 years in the pharmaceutical/biotech industry in various leadership positions, ranging from discovery to safety. Prior to the industry, he did a M.Sc. in experimental biology and a Ph.d. and post doc within immunology/medicine. He has supervised M.Sc. and Ph.d. students, participated in several research boards bridging industry and academia and has 40+ peer reviewed co-authorships in international journals.